Pfizer and Moderna apparently ruled out any prospect of sharing their mRNA technology-based vaccines with the vaccine firms in developing countries on grounds that they are far too complex and require more than 100 raw materials.

Pfizer and Moderna apparently ruled out any prospect of sharing their mRNA technology-based vaccines with the vaccine firms in developing countries on grounds that they are far too complex and require more than 100 raw materials.
Bonn, 26 June (TWN) – Disagreements between developed and developing countries arose over the need to review the progress on achievements under the UNFCCC, at the Bonn climate talks. The talks which began on 17 June, are scheduled to end…